NEW YORK, June 2 — Pfizer Inc and partner BioNTech have completed the filing with the US drugs regulator seeking authorisation for their Covid-19 vaccine in children under 5 years of age.

The companies filed data with the US Food and Drug Administration showing three lower-dose shots of the vaccine generated a strong immune response in children as young as 6 months of age. — Reuters